Article

Preparing to Exercise

What to know before beginning an exercise program

Everyone can do some type of activity. But it’s important that patients keep in mind a few general precautions before exercising during cancer treatment.

Patients who were already active may have to slow down a bit during treatment and perhaps not exercise as intensely as they had before. They should assess how they feel and avoid pushing themselves. It’s important for patients to communicate with their healthcare providers about their planned physical activities before they begin.

People who were sedentary before should start slowly, adding more intensity and frequency as they are able. Patients should consider how active they were before treatment and adjust accordingly.

Side effects of treatment can determine the most appropriate type of exercise. For example, someone with neuropathy may have numb toes, which would make riding a stationary bike a better choice than walking on a treadmill. Patients experiencing lymphedema have long been discouraged from upper body strength training or vigorous activity, but a number of clinical trials have shown that not only are these activities safe for these individuals, but also may actually reduce the incidence and severity of lymphedema. Patients must talk to their doctors to determine what is safe.

Patients who are undergoing frequent chemotherapy treatments may have lower immune function and should avoid working out in public places, such as gyms. People who are having skin reactions from radiation treatments and those with open wounds or catheters should avoid swimming in chlorinated pools.

An upper-body port may necessitate temporarily avoiding upper-body strength training. Patients with advanced disease who experience limitations due to bone metastases should discuss exercise with their healthcare provider and generally use pain or discomfort as a guide for what type of activity to avoid.

[Staying Active During Treatment]

Related Videos
Dr. Andreas M. Kaiser is a professor and chief of the Division of Colorectal Surgery in the Department of Surgery at City of Hope comprehensive cancer center in Duarte, California.
Dr. Guru Sonpavde emphasized the importance of better understanding how genetic mutations influence the treatment of cancer care, particularly GU cancers.
Image of woman with blonde hair.
Dr. Frederick L. Locke sat down with CURE® to discuss treatment with cema-cel in the ALPHA/ALPHA2 studies for relapsed/refractory large B-cell lymphoma.
Dr. Park sat down for an interview with CURE® to discuss the key takeaways from the 2025 Annual ASCO Genitourinary Cancers Symposium.
Treatment with cemacabtagene ansegedleucel demonstrated responses in patients with relapsed or treatment-resistant large B-cell lymphoma.
There was no evidence that CAR T directly caused secondary malignancies, despite FDA warnings, citing prior treatments as the cause, according to research.
Image of Dr. Christopher R. Flowers.
a man and a woman in front of a dark blue background
a man and a woman in front of a dark blue background
Related Content